Krajina: Spojené kráľovstvo
Jazyk: angličtina
Zdroj: VMD (Veterinary Medicines Directorate)
Chlamydophila felis, Feline calicivirus, Feline leukemia virus, Feline panleukopenia virus, Feline viral rhinotracheitis virus
Schering-Plough Ltd
QI06AJ04
Chlamydophila felis, Feline calicivirus, Feline leukemia virus, Feline panleukopenia virus, Feline viral rhinotracheitis virus
Expired
Issued 11/12/2009 – AN 00841/2007 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Procyon Cat HCChlam/PFeLV Lyophilisate and solvent for suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION i. HCChlam – freeze dried fraction Names of substances Quantity per dose (reconstituted) (log 10 TCID 50 /mL 1 ) Active ingredients Live, attenuated: Feline Rhinotracheitis virus (F2 strain) ≥ 4.9 Feline Calicivirus (F-9 strain) ≥ 4.4 Feline Pneumonitis (Baker Strain) ( _Chlamydophila_ _ felis_) ≥ 3.4 ii. PFeLV – liquid diluent fraction Names of substances Quantity per 1 ml dose Active ingredients Inactivated: Feline Panleucopenia Virus (Dow 13-001 strain) ≥ 7.13 log 2 SNT 2 Feline Leukaemia Virus (Rickard strain) ≥ 1.0 RP 3 Adjuvant Carbopol 981 solution 20% v/v 1 Tissue Culture Infective Dose 2 Value in Guinea Pig Potency Test 3 Relative Potency Units are derived from ELISA For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Lyophilisate and solvent for suspension for injection 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the active immunisation of cats from 8 weeks of age. To reduce clinical signs and shedding caused by infection with Feline Rhinotracheitis virus (FVR), Feline Calicivirus (FCV) and Feline Pneumonitis (FPN). To provide protection against Feline Panleucopenia (FPL). To prevent persistent viraemia caused by infection with Feline Leukaemia Virus (FeLV). 1/4 Issued 11/12/2009 – AN 00841/2007 Immunity has been demonstrated following completion of the primary vaccination course at: 2 weeks for FeLV, 3 weeks for FPL and 4 weeks for FVR, FCV and FPN. Duration of immunity has been demonstrated following completion of the primary course for at least: 4 years for FPL, 3 y Prečítajte si celý dokument